Surgical Procedures Volume Market

Surgical Procedures Volume Market Outlook (2025 to 2035)

The surgical procedures volume market is valued at USD 2.28 billion in 2025. As per FACTMR’s analysis, the surgical procedures volume industry will grow at a CAGR of 6% and reach USD 4.09 billion by 2035. Healthcare infrastructure development has greatly driven the growth of outpatient surgical procedures, leading to increased use of surgical devices and implants.

In 2024, the volume of surgical procedures segment saw significant expansion, fostered by increasing incidences of chronic diseases and a focus on more outpatient care. The trend of minimally invasive and robot-assisted surgeries continued to build steam, as advancements in technology improved procedural efficiency and patient experience. Growing healthcare expenditure, especially in developing nations, further fueled demand for surgical devices and implants.

Looking forward to 2025, the industry is likely to grow gradually with the aging global population and increased hospitalization rates. Advances in surgical navigation systems and artificial intelligence-supported procedures will continue to enhance surgical accuracy, driving increasing adoption across medical facilities. Moreover, an increase in gynecological interventions and increased awareness of specialist surgical procedures will support overall growth.

Metric	Value
Industry Value (2025E)	USD 2.28 billion
Industry Value (2035F)	USD 4.09 billion
CAGR (2025 to 2035)	6%

Market Analysis

The volume of the surgical procedures industry is poised for long-term growth as minimally invasive technology improves, and there is greater demand for outpatient treatments. Demographics of aging populations, hospitalization rates on the rise, and surgical system technological advancements will drive further growth. Benefactors include healthcare providers and manufacturers of medical devices, while traditional segments for invasive procedures are likely to suffer as patients increasingly seek less invasive options.

Top 3 Strategic Imperatives for Stakeholders

Invest Faster in Minimally Invasive and Robotic-Assisted Procedures

R&D and investment in minimally invasive and robotic-assisted surgical technology should be the focus for stakeholders to improve accuracy, minimize recovery time, and address changing patient demands.

Leverage Outpatient and Ambulatory Surgical Center (ASC) Expansion

Partnering more aggressively with ASCs and outpatient centers will be essential as demand turns towards cost-efficient, patient-friendly procedures. Firms need to position products to address exclusively this expanding segment.

Strengthen Global Distribution and Industry Penetration

Increasing supply chain efficiency, establishing strategic partnerships in high-growth sectors, and exploring mergers and acquisitions will enable industry participants to extend their reach and tap into untapped demand, particularly in emerging sectors.

Top 3 Risks Stakeholders Should Monitor

Risk	Probability - Impact
Regulatory Uncertainty & Compliance Issues - Tighter healthcare regulations and changing approval procedures could lengthen product launch timing and increase compliance expenses.	High - High
Supply Chain Risks & Material Shortages - Global supply chain disruptions, geopolitical tension, and raw material shortages may affect production efficiency and drive costs higher.	Medium - High
Technological Developments & Competitive Displacement - Sudden developments in AI-based and robotic-assisted surgeries can make current surgical technologies outdated, forcing stakeholders to invest more in R&D.	High - Medium

1-Year Executive Watch List

Priority	Immediate Action
Regulatory Preparedness	Improve regulatory acumen to better anticipate changing compliance standards and reduce approval cycles.
Supply Chain Resilience	Develop alternative sourcing plans and regional supplier alliances to reduce disruptions and cost volatility.
Technological Innovation	Accelerate R&D on AI-supported and robotic surgeries while building partnerships with medtech startups for advanced developments.

For the Boardroom

To stay ahead, companies need to propel innovation in AI-enabled and minimally invasive surgical technologies while strengthening regulatory flexibility and supply chain resilience. Strategic R&D investments, further integration with ambulatory surgical centers, and nimble sourcing initiatives will be essential for long-term competitiveness. This insight redefines the roadmap, prioritizing proactive adaptation to future healthcare trends, guaranteeing sustained leadership and profitability in a fast-changing environment.

Segment-Wise Analysis

By Procedure Type

Cardiovascular procedures are also anticipated to exhibit strong growth since the incidence of heart diseases remains on the upswing, mostly among the ageing population. Minimal invasive methods and robotic surgeries will be driving such growth, yielding patients with rapid recovery and superior outcomes. Neurosurgery procedures will also see significant growth as a result of the rising prevalence of neurological disorders like brain tumors and spinal disorders.

Orthopedic surgeries, especially joint replacement, fracture care, and trauma procedures, are expected to increase in size. Aging population, along with advances in joint implants and minimally invasive surgical approaches, will fuel the demand for these procedures. Ophthalmic surgery, such as cataract operations and laser vision correction, will continue to expand with the increasing population of elderly individuals and the technological advancements in surgical procedures.

Gynecology procedures will experience robust growth, driven by growing women's health awareness, the prevalence of gynecological disorders on the rise, and greater numbers of women opting for preventive and corrective procedures. Other surgeries, covering a range of various surgical disciplines, will also witness consistent expansion. These include dermatological procedures, urology procedures, and bariatric surgery procedures, spurred by technical advancements in procedures, improved awareness among patients, and available treatments.

The procedure type segment overall is anticipated to grow at a CAGR of 6.4% from 2025-2035.

Country-Wise Analysis

United States

The United States industry is on the back of the developments in robotic and minimally invasive surgery. Increasing chronic diseases such as cardiovascular ailments and musculoskeletal conditions, coupled with an aging population, will drive demand. Furthermore, the emphasis of the healthcare infrastructure on outpatient surgery and technological advancements in surgical equipment will also propel growth.

The use of precision medicine and surgical systems aided by AI will also have a huge role to play in the future of surgery in the U.S. As medical technology keeps advancing, the nation is likely to experience huge growth in many surgical areas. FACTMR opines that the CAGR of the United States is projected to be 6.3% from 2025 to 2035.

India

India's surgical procedures industry is expected to grow strongly as a result of the country's large and increasing population, increasing healthcare awareness, and growing middle class. The rising incidence of lifestyle diseases, including diabetes and cardiovascular diseases, is generating greater demand for surgical interventions.

The trend towards medical tourism and the development of healthcare infrastructure in urban and rural areas will also drive this growth. Improvement in cost-effective surgical technologies and rising government efforts to boost the accessibility of healthcare will continue to drive growth. FACTMR forecasts that India's CAGR is projected to be 6.7% from 2025 to 2035.

China

China will experience fast growth in the surgical procedures industry, fuelled by its massive and ageing population, increasing healthcare expenditure, as well as an increasing chronic disease burden. The government's emphasis on improving healthcare availability, especially in rural regions, will be central to the expansion.

Also, the need for sophisticated procedures like robotic and minimally invasive procedures will grow with the lower costs of technology. The advances in medical research in China and the strong healthcare infrastructure will help drive the volume of surgical procedures.

FACTMR opines that the CAGR of China is projected to be 6.5% from 2025 to 2035.

United Kingdom

The UK's surgical procedures industry will grow steadily, driven by a growing population and rising healthcare needs. With the evolution of surgical procedures like minimally invasive surgery, robotic surgery, and the rising popularity of outpatient surgery, the nation will experience greater procedure volumes.

The National Health Service (NHS) will remain central to delivering surgical services, although there will be a growing dependence on independent healthcare providers for increased demand. The use of advanced technologies in surgery will also drive this growth.

FACTMR opines that the CAGR of the United Kingdom is projected to be 6.1% from 2025 to 2035.

Germany

Germany's surgical procedures industry will witness steady growth fueled by its sophisticated healthcare system, high healthcare spending, and fast-aging population. The nation's emphasis on innovation, especially robotic and minimally invasive surgery, will be the key driver of this growth.

The increasing prevalence of chronic conditions, including cardiovascular diseases and orthopedic conditions, will drive the rising demand for surgical interventions. In addition, Germany's leadership in medical technology will further contribute to the development of the surgical procedures industry. FACTMR forecasts that the CAGR of Germany is projected to be 6.2% from 2025 to 2035.

South Korea

South Korea's surgical procedures industry is expected to grow significantly because of its sophisticated medical technology, rising demand for minimally invasive procedures, and rising aging population. South Korea is famous for its advanced surgical technologies, such as robotic and laser surgery, which are likely to propel growth.

Rising awareness of preventive healthcare and wellness will lead to greater demand for surgeries. Also, the rapidly growing South Korean medical tourism industry will increase the need for surgical treatments. FACTMR is of the opinion that the CAGR of South Korea is projected to be 6.4% from 2025 to 2035.

Japan

Japan's surgical procedures volume industry will undergo moderate but constant growth, based on its increasing population and higher incidence of age-related health ailments. Japan has a leading role in medical technology, and the utilization of robotic and minimally invasive procedures will also grow further.

The need for surgical interventions will grow as medical policies focus more on the prevention and treatment of long-term diseases. The growth in outpatient and day surgery centers will further add to the growth in this segment. FACTMR forecasts that Japan's CAGR is projected to be 6.0% from 2025 to 2035.

France

France is likely to experience solid expansion in the surgical procedures volume industry as a result of its sophisticated healthcare system, aging population, and spreading prevalence of chronic diseases. The French healthcare system's focus on enhancing patient outcomes with minimally invasive and robot-assisted surgeries will fuel growth. The adoption of new medical technologies by the country will further propel surgical procedure volumes, especially in specialties such as cardiology and orthopedics.

FACTMR opines that the CAGR of France is projected to be 6.2% from 2025 to 2035.

Italy

Italy's industry for surgical procedures is expected to increase steadily, driven by the robust healthcare system of the country and the growing demand for surgical procedures due to the aging population. The Italian healthcare industry is embracing advanced surgical technologies, especially in orthopedic and ophthalmic surgeries.

The ever increasing emphasis on outpatient surgery and minimally invasive procedures will also drive demand. The government's healthcare policies to enhance the accessibility of surgery will also drive this growth.

FACTMR projects that the CAGR of Italy is projected to be 6.1% from 2025 to 2035.

Australia-New Zealand

Australia and New Zealand will see steady growth in their industry of surgical procedures due to their advanced healthcare systems, high-standard medical care, and aging population. Demand for complex surgical treatments, especially in orthopedic, cardiovascular, and gynecologic procedures, will rise.

Increased adoption of minimally invasive surgical procedures and robot-assisted surgery will continue to drive the industry. Growing incidences of lifestyle disorders will further lead to an increase in surgical procedure volumes in both countries.

FACTMR forecasts that the CAGR of Australia-New Zealand is projected to be 6.3% from 2025 to 2035.

FACTMR Survey Results: Surgical Procedures Volume Industry Dynamics based on Stakeholder Perspectives

(Surveyed Q4 2024, n=450 stakeholder participants evenly distributed across manufacturers, distributors, healthcare providers, and patients in the US, Western Europe, Japan, and South Korea)

Key Priorities of Stakeholders

• Healthcare Regulations Compliance: 80% of all stakeholders across the world recognized compliance with healthcare regulations, such as safety and quality measures, as a "critical" priority.
• Technological Innovations: 74% of the participants recognized the necessity of implementing innovative surgical technologies like robotic surgeries and minimal invasive techniques in order to enhance surgical results.

Regional Difference:

• US: 65% of the stakeholders recognized innovation in outpatient surgeries as a requirement in order to be cost-effective.
• Western Europe: 87% emphasized sustainability and minimizing the environmental footprint of surgical interventions.
• Japan/South Korea: 58% identified the increasing need for precision surgeries due to an aging population and high levels of healthcare.

Adopting Advanced Technologies

High Variance

• US: 55% of clinics and hospitals have embraced robotic-assisted surgical systems, particularly for high-demand procedures like orthopedics and cardiology.
• Western Europe: 48% of healthcare practitioners employ sophisticated surgery technologies like AI-based systems for enhanced surgery planning and recovery to improve outcomes, with Germany (53%) showing the highest level of adoption.
• Japan: 32% of healthcare establishments employ cutting-edge technology, with a focus on robotic surgery, but the level of adoption is slower because of cost factors.
• South Korea: 40% have incorporated advanced systems such as robotic-assisted surgeries in urban cities, stimulated by the need for precision operations in metropolitan hospitals.

Convergent and Divergent Views on ROI:

• US: 75% of stakeholders believe high returns on investment (ROI) from automation and robotic surgery, while 45% of stakeholders in Japan are still reluctant due to costs.

Material Preferences

Consensus

• Steel: 68% of stakeholders across the world choose steel for surgical instruments and implants due to its strength and endurance in high-stress medical conditions.

Variance

• Western Europe: 56% favor light aluminum materials for surgical instruments and equipment, fueled by sustainability requirements and convenience of mobility in ambulatory surgical centers.
• Japan/South Korea: 44% of those interviewed prefer hybrid materials like stainless steel and titanium in order to maintain corrosion resistance along with strength for surgical implants due to the desire for high performance in long-term use.
• US: 72% prefer stainless steel for its durability, especially for use in hospitals where there is heavy surgical throughput.

Price Sensitivity

Shared Challenges

• Increasing Cost of Materials: 82% of the stakeholders across the world listed increasing costs of surgical materials, particularly steel and titanium, as a major challenge.

Regional Differences

• US/Western Europe: 64% would pay a premium (15-20%) for cutting-edge technology, specifically robotic surgeries, since the benefit of better patient outcomes is worth incurring the extra expense.
• Japan/South Korea: 79% seek cost-effective surgical options, with 15% accepting basic options in an effort to contain costs, emphasizing lower-cost technologies.
• South Korea: 50% would consider leasing models to reduce initial equipment expenses, especially in automated surgical systems.

Pain Points in the Value Chain

Manufacturers

• US: 60% have trouble handling supply chain interruptions and raw material shortages, particularly from increasing worldwide demand for surgical instruments.
• Western Europe: 52% have trouble complying with regulations, mainly keeping up with the tight EU standards for medical devices.
• Japan: 58% experience retarded product uptake from cost barriers and conservative rates of adoption for new surgical technologies.

Distributors

• US: 68% point to late shipment by foreign suppliers, especially of essential surgical instruments.
• Western Europe: 45% grapple with competition from cheaper Eastern European producers.
• Japan/South Korea: 63% point to rural delivery logistics issues and cost containment for transporting surgical equipment.

End-Users (Healthcare Providers)

• US: 50% point to delayed treatment times for patients because of delayed surgical procedures and lack of equipment.
• Western Europe: 42% are concerned with retrofitting older operating rooms to support new robotic-assisted surgical systems.
• Japan: 55% are concerned with the lack of proper training for personnel on advanced surgical technologies.

Future Investment Priorities

Alignment

• 68% of worldwide stakeholders intend to invest in advanced surgical technologies such as robotic-assisted systems, AI-based diagnostics, and sophisticated surgical planning tools.

Divergence

• US: 62% are investing in patient monitoring systems and sophisticated surgical tools that enhance procedural precision.
• Western Europe: 57% are interested in sustainable production processes for surgical devices, with specific emphasis on minimizing the environmental footprint of surgical waste.
• Japan/South Korea: 48% are spending money on space-saving surgical devices for space-restricted hospitals, particularly in urban cities.

Regulatory Impact

• US: 72% of the stakeholders mentioned that regulations at the state level, e.g., California's highly regulatory medical device rules, play an important role in the decision-making process regarding surgical procedures and devices.
• Western Europe: 85% of stakeholders regard the EU Medical Device Regulation (MDR) as a driving factor for higher quality, more complex surgical equipment take-up despite compliance complexity escalating.
• Japan/South Korea: Regulations affect purchasing decisions slightly, by just 30% of stakeholders reporting, given less stringent enforcement being perceived than other regions.

Conclusion: Consensus vs. Variance

High Consensus:

• Adherence to healthcare regulations, durability, and the requirement for sophisticated technologies are worldwide uniform concerns.

Key Variances:

• US: Strong automation and robotic surgery focus vs. Japan/South Korea: Conservative strategies with greater price sensitivity.
• Western Europe: Pioneering sustainability strategies in surgical devices vs. Asia: Material hybrids emphasize cost-performance balance.

Strategic Insight:

• A regional need-based customized approach is needed by stakeholders seeking success in the global volume industry of surgical procedures, since technology upgradation and environmental concerns are not always top priority.

Government Regulations

Country	Impact of Government Regulations and Policies
United States	Strict FDA regulations for medical equipment and devices, such as surgical instruments and implants. Firms need to get FDA approval and follow the Food, Drug, and Cosmetic Act.
India	Regulatory framework under the Central Drugs Standard Control Organization (CDSCO) regulates medical devices. Compulsory certification of surgical equipment under the Medical Devices Rules (MDR).
China	National Medical Products Administration (NMPA) requires surgical equipment to be certified, primarily for safety specifications of medical devices. Registration applies to all surgical instruments.
United Kingdom	The UK requires the UKCA (UK Conformity Assessed) mark on medical devices in the post-Brexit scenario. The regulatory guidelines are followed by the Medicines and Healthcare products Regulatory Agency (MHRA).
Germany	Compliance with EU MDR laws, where CE marking of medical devices, such as surgical instruments, is mandatory. Environmental standards and sustainability are also given priority in Germany for surgical items.
South Korea	Mandatory registration is enforced by Korean Food and Drug Administration (KFDA) for surgical instruments. Compliance with the Medical Device Act must be ensured to enter the industry.
Japan	Japan's Pharmaceuticals and Medical Devices Agency (PMDA) requires approval for surgical devices. Japanese law focuses on safety and efficacy of medical instruments, and firms need to acquire PMDA certification.
France	Surgical devices need to meet CE marking under the EU MDR. France's regulatory environment also focuses on patient safety and environmental sustainability for medical products.
Italy	Complies with EU MDR regulations and needs CE certification for surgical devices. Italy also has a national regulatory agency, the Italian Medicines Agency (AIFA), imposing medical device standards.
Australia-New Zealand	In Australia, surgical devices need to be compliant with Therapeutic Goods Administration (TGA) standards, whereas in New Zealand, the Ministry of Health imposes compliance with local medical device standards.

Competitive Landscape

The industry for surgical procedures volume is still fragmented, with numerous companies competing for market supremacy based on competitive prices, innovation, strategic alliances, and regional expansion.

Market leaders make various strategies to increase their presence in the industry. Pricing is a deciding factor, as companies desire to provide competitive pricing with profitability in mind. Innovation is a driving force, where companies are spending on sophisticated technologies like robotic-assisted surgeries and minimally invasive procedures to enhance patient results and efficiency.

Stryker Corporation's acquisition of Inari Medical in December 2024 for $4.9 billion strengthens its vascular medical device portfolio. Johnson & Johnson's MedTech business also acquired Shockwave Medical in May 2024 for $13.1 billion, combining advanced intravascular lithotripsy technology to address calcified arterial plaque.

Moreover, Zimmer Biomet's buyout of Paragon 28 for $1.1 billion in January 2025 reinforces its dominance in the orthopedic device space, namely foot and ankle procedures.

Market Share Analysis

• Medtronic (18.4%) - Cardiac, spinal, and general surgery devices global industry leader.
• Johnson & Johnson - Ethicon (16.2%) - Leader in minimally invasive and robotic-assisted surgical solutions.
• Stryker (12.7%) - Key leader in orthopedic, neurovascular, and trauma surgeries.
• Boston Scientific (9.5%) - Interference in interventional cardiology, endoscopy, and urology procedures.
• Becton Dickinson - BD (7.8%) - Surgical instrument and infection prevention product major supplier.
• Intuitive Surgical (6.3%) - Leader in robotic-assisted surgery (da Vinci systems).

Key Industry Players Include

• Medtronic
• Johnson & Johnson (Ethicon)
• Stryker
• Boston Scientific
• Becton Dickinson (BD)
• Intuitive Surgical
• Zimmer Biomet
• Olympus Corporation
• CONMED Corporation
• Smith & Nephew
• Abbott Laboratories
• Terumo Corporation
• Getinge AB
• Karl Storz
• Hologic

Segmentation

By Procedure Type:

Cardiovascular Procedures, Neurosurgery Procedures, Orthopedic Procedures, Ophthalmic Procedures, Gynecology Procedures, Other Procedures

By Region:

North America, Europe, Asia Pacific, Middle East & Africa, Latin America